Journal of the Canadian Association of Gastroenterology
17 papers18 directions
The Journal of the Canadian Association of Gastroenterology is a clinical publication focused on digestive health and the study of gastrointestinal pathologies. Between 2022 and 2026, the venue has contributed to the medical literature through retrospective analyses, systematic reviews, and meta-analyses of randomized controlled trials. Its content primarily addresses clinical outcomes and diagnostic trends, including the management of irritable bowel syndrome, gastric neoplasia, and various forms of polyposis.
Research published in this venue frequently explores endoscopic therapies and quality indicators for conditions such as Barrett’s esophagus and Dieulafoy’s lesions. Specific areas of investigation include the efficacy of fecal microbiota transplantation and the role of signaling effectors like YAP and TAZ in gastric tumorigenesis. Prolific contributors to the journal include researchers such as Arman Walia, Eric Lam, Neal Shahidi, and Alan Barkun, who focus on evaluating therapeutic interventions and patient outcomes within tertiary gastroenterology practices.
In the context of machine learning and data-driven research, the venue serves as a source for clinical evidence and structured datasets that inform medical modeling. While its primary focus is clinical, the retrospective cohort studies and meta-analyses provide the foundational data necessary for developing predictive tools in gastroenterology. The journal’s emphasis on systematic reviews and large-scale retrospective studies offers a repository of clinical outcomes relevant to researchers applying computational techniques to improve diagnostic accuracy and treatment protocols in digestive diseases.
Papers by Year
| 2026 | 2 |
| 2025 | 7 |
| 2024 | 4 |
| 2023 | 2 |
| 2022 | 2 |
Top Research Directions
Research directions most represented by papers from this venue.
Top Authors
| Author | Papers |
|---|---|
| Mingyang Shan | 1 |
| Sechiv Jugnundan | 1 |
Impactful Papers
Papers from this venue that shaped research clusters.
Influential
A201 EFFECT OF MIRIKIZUMAB ON BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT AND REMISSION: RESULTS
influential
Quantifying Clinical Relevance Beyond St
2023